Nearly 90,000 Maryland jobs come from the state's 400 biotechnology companies, so when a senior Democrat on the Senate committee looking into industry regulations asks for a meeting, local businesses are the first to the table.
Sen. Barbara Mikulski, D-Md., met with representatives from several Frederick County biotech companies Tuesday at MedImmune, a Frederick-based pharmaceutical firm. The discussion, the third stop on Mikulski's Maryland biotech listening tour, focused on the Prescription Drug User Fee Act and the Medical Device User Fee Act.